Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2297
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Molecular Targeting of Cell-Permeable Peptide Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation

Oncotarget
Oncology
2017English

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2017English

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Current Molecular Medicine
BiochemistryMedicineMolecular MedicineMolecular Biology
2016English

MicroRNA‑766 Inhibits the Malignant Biological Behaviours of Pancreatic Ductal Adenocarcinoma by Directly Targeting ETS1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

The Impact of a History of Cancer on Pancreatic Ductal Adenocarcinoma Survival

United European Gastroenterology Journal
OncologyGastroenterology
2018English

Proteasome Inhibitor MG132 Suppresses Pancreatic Ductal Adenocarcinoma‑cell Migration by Increasing ESE3 Expression

Oncology Letters
Cancer ResearchOncology
2019English

The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y2 Purinergic Receptor

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Targeting the Prohibitin Scaffold-Craf Kinase Interaction in RAS-ERK-driven Pancreatic Ductal Adenocarcinoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma

Cancer
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy